212 related articles for article (PubMed ID: 18985676)
21. Early response as assessed by anatomic imaging does not predict failure-free survival among patients with Group III rhabdomyosarcoma: a report from the Children's Oncology Group.
Rosenberg AR; Anderson JR; Lyden E; Rodeberg DA; Wolden SL; Kao SC; Parham DM; Arndt C; Hawkins DS
Eur J Cancer; 2014 Mar; 50(4):816-23. PubMed ID: 24361229
[TBL] [Abstract][Full Text] [Related]
22. Rhabdomyosarcoma in children. Correlation of form and prognosis in one institution's experience.
Hawkins HK; Camacho-Velasquez JV
Am J Surg Pathol; 1987 Jul; 11(7):531-42. PubMed ID: 3605489
[TBL] [Abstract][Full Text] [Related]
23. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV.
Baker KS; Anderson JR; Link MP; Grier HE; Qualman SJ; Maurer HM; Breneman JC; Wiener ES; Crist WM
J Clin Oncol; 2000 Jun; 18(12):2427-34. PubMed ID: 10856103
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997.
Blakely ML; Andrassy RJ; Raney RB; Anderson JR; Wiener ES; Rodeberg DA; Paidas CN; Lobe TE; Crist WM;
J Pediatr Surg; 2003 Mar; 38(3):347-53. PubMed ID: 12632347
[TBL] [Abstract][Full Text] [Related]
25. Rhabdomyosarcoma with isolated lung metastases: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Vasquez JC; Luo LY; Hiniker SM; Rhee DS; Dasgupta R; Chen S; Weigel BJ; Xue W; Venkatramani R; Arndt CA
Pediatr Blood Cancer; 2023 Jun; 70(6):e30293. PubMed ID: 36916768
[TBL] [Abstract][Full Text] [Related]
26. Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: the Intergroup Rhabdomyosarcoma Study-IV experience--a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Burke M; Anderson JR; Kao SC; Rodeberg D; Qualman SJ; Wolden SL; Meyer WH; Breitfeld PP;
J Clin Oncol; 2007 Nov; 25(31):4909-13. PubMed ID: 17971587
[TBL] [Abstract][Full Text] [Related]
27. Soft-tissue sarcomas in childhood. A study of 262 cases including 169 cases of rhabdomyosarcoma.
Harms D; Schmidt D; Treuner J
Z Kinderchir; 1985 Jun; 40(3):140-5. PubMed ID: 4036365
[TBL] [Abstract][Full Text] [Related]
28. Machine learning for rhabdomyosarcoma histopathology.
Frankel AO; Lathara M; Shaw CY; Wogmon O; Jackson JM; Clark MM; Eshraghi N; Keenen SE; Woods AD; Purohit R; Ishi Y; Moran N; Eguchi M; Ahmed FUA; Khan S; Ioannou M; Perivoliotis K; Li P; Zhou H; Alkhaledi A; Davis EJ; Galipeau D; Randall RL; Wozniak A; Schoffski P; Lee CJ; Huang PH; Jones RL; Rubin BP; Darrow M; Srinivasa G; Rudzinski ER; Chen S; Berlow NE; Keller C
Mod Pathol; 2022 Sep; 35(9):1193-1203. PubMed ID: 35449398
[TBL] [Abstract][Full Text] [Related]
29. Histopathological classification of childhood rhabdomyosarcoma: a report from the International Society of Pediatric Oncology pathology panel.
Caillaud JM; Gérard-Marchant R; Marsden HB; van Unnik AJ; Rodary C; Rey A; Flamant F
Med Pediatr Oncol; 1989; 17(5):391-400. PubMed ID: 2477674
[TBL] [Abstract][Full Text] [Related]
30. Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology group.
Spunt SL; Smith LM; Ruymann FB; Qualman SJ; Donaldson SS; Rodeberg DA; Anderson JR; Crist WM; Link MP
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6072-9. PubMed ID: 15447992
[TBL] [Abstract][Full Text] [Related]
31. Juvenile rhabdomyosarcomas in Port Harcourt, Nigeria: A twelve year review.
Seleye-Fubara D; Etebu EN
West Afr J Med; 2006; 25(1):57-60. PubMed ID: 16722360
[TBL] [Abstract][Full Text] [Related]
32. Non-Rhabdomyosarcoma Soft Tissue Sarcomas in Children: A Surveillance, Epidemiology, and End Results Analysis Validating COG Risk Stratifications.
Waxweiler TV; Rusthoven CG; Proper MS; Cost CR; Cost NG; Donaldson N; Garrington T; Greffe BS; Heare T; Macy ME; Liu AK
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):339-48. PubMed ID: 25968827
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics and the prognosis of childhood rhabdomyosarcoma in 60 patients treated at a single institute.
Company F; Pedram M; Rezaei N
Acta Med Iran; 2011; 49(4):219-24. PubMed ID: 21713731
[TBL] [Abstract][Full Text] [Related]
34. Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IV.
Pappo AS; Meza JL; Donaldson SS; Wharam MD; Wiener ES; Qualman SJ; Maurer HM; Crist WM
J Clin Oncol; 2003 Feb; 21(4):638-45. PubMed ID: 12586800
[TBL] [Abstract][Full Text] [Related]
35. Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
Rodeberg DA; Wharam MD; Lyden ER; Stoner JA; Brown K; Wolden SL; Paidas CN; Donaldson SS; Hawkins DS; Spunt SL; Arndt CA
Int J Cancer; 2015 Jul; 137(1):204-11. PubMed ID: 25418440
[TBL] [Abstract][Full Text] [Related]
36. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma.
Paner GP; McKenney JK; Epstein JI; Amin MB
Am J Surg Pathol; 2008 Jul; 32(7):1022-8. PubMed ID: 18469707
[TBL] [Abstract][Full Text] [Related]
37. Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Sung L; Anderson JR; Donaldson SS; Spunt SL; Crist WM; Pappo AS;
Eur J Cancer; 2004 Aug; 40(12):1878-85. PubMed ID: 15288290
[TBL] [Abstract][Full Text] [Related]
38. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
Dantonello TM; Int-Veen C; Harms D; Leuschner I; Schmidt BF; Herbst M; Juergens H; Scheel-Walter HG; Bielack SS; Klingebiel T; Dickerhoff R; Kirsch S; Brecht I; Schmelzle R; Greulich M; Gadner H; Greiner J; Marky I; Treuner J; Koscielniak E
J Clin Oncol; 2009 Mar; 27(9):1446-55. PubMed ID: 19224858
[TBL] [Abstract][Full Text] [Related]
39. Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee.
Crist WM; Garnsey L; Beltangady MS; Gehan E; Ruymann F; Webber B; Hays DM; Wharam M; Maurer HM
J Clin Oncol; 1990 Mar; 8(3):443-52. PubMed ID: 2407808
[TBL] [Abstract][Full Text] [Related]
40. Future directions in risk stratification and therapy for advanced pediatric genitourinary rhabdomyosarcoma.
Harel M; Ferrer FA; Shapiro LH; Makari JH
Urol Oncol; 2016 Feb; 34(2):103-15. PubMed ID: 26519985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
